If you have been reading about HPLC-UV and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also marketed informally as Stenabolic |
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ |
| Molecular formula | C24H30ClN3O4S | Approximate molecular weight 492 g/mol |
| CAS Registry Number | 1379686-30-2 | Identifier for the parent compound |
| Regulatory status | Not approved for human use | Prohibited in sport by WADA |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
in the PAMn matrix represents the number of mutations per 100 amino acids, which can be likened to a percentage of mutations, the term percentage accepted mutation is sometimes used. It is important to distinguish between point accepted mutations (PAMs), point accepted mutation matrices (PAM matrices) and the PAMn matrix. The term 'point accepted mutation' refers to the mutation event itself. However, 'PAM matrix' refers to one of a family of matrices which contain scores representing the likelihood of two amino acids being aligned due to a series of mutation events, rather than due to random chance. The 'PAMn matrix' is the PAM matrix corresponding to a time frame long enough for
In 1958, the RCAF retired its 78 remaining Mustangs. RCAF pilot Lynn Garrison ferried them from their various storage locations to Canastota, New York, where the American buyers were based. Garrison flew each of the surviving aircraft at least once. These aircraft make up a large percentage of the aircraft presently flying worldwide. The most prominent firm to convert Mustangs to civilian use was Trans-Florida Aviation, later renamed Cavalier Aircraft Corporation, which produced the Cavalier Mustang. Modifications included a taller tailfin and wingtip tanks. Conversions included a Cavalier Mustang specialty: a "tight" second seat added in the space formerly occupied by the military radio and fuselage fuel tank. In the late 1960s and early 1970s, when the United States Department of Defense wished to supply aircraft to South American countries and later Indonesia for close air support and counterinsurgency, it paid Cavalier to return some of their civilian conversions back to updated military specifications. In the 21st century, a P-51 can command a price of more than $1 million, even for only partially restored aircraft. There were 204 privately owned P-51s in the US on the FAA registry in 2011, most of which are still flying, often associated with organizations such as the Commemorative Air Force (formerly the Confederate Air Force).
Purification in a chemical context is the physical separation of a chemical substance of interest from foreign or contaminating substances. Pure results of a successful purification process are termed isolate. The following list of chemical purification methods should not be considered exhaustive.
Concept had a remake by Felix Wankel, a self-taught tightness specialist, never had an engineer diploma, neither a driver's license, for the Torpedo engine Jumo KM-8. Itala (company) succeeded in a different type of Rotary Valve. In Britain, the National Engine Company Ltd advertised its rotary valve engine for use in early aircraft, at a time when poppet valves were prone to failure by sticking or burning. In the end of 1930s, Frank Aspin developed a design with a rotary valve that rotated on the same axis as the cylinder bore, but with limited success. US company Coates International Ltd has developed a spherical rotary valve for internal combustion engines which replaces the poppet valve system. This particular design is four-stroke, with the rotary valves operated by overhead shafts in lieu of overhead camshafts (i.e. in line with a bank of cylinders). The first sale of such an engine was part of a natural gas engine-generator. Rotary valves are potentially highly suitable for high-revving engines, such as those used in racing sportscars and F1 racing cars, on which traditional poppet valves with springs can fail due to valve float and spring resonance and where the desmodromic valve gear is too heavy, large in size and too complex to time and design properly. Rotary valves could allow for a more compact and lightweight cylinder head design. They rotate at half engine speed (or one quarter) and lack the inertia forces of reciprocating valve mechanisms. This allows for higher engine speeds, offering approximately perhaps 10% more power.
Sources: en.wikipedia.org
=== Biomedical applications === Ethyl carbamate was originally used as an antineoplastic agent, hypnotic, sclerosing agent, adjunct to sulfonamide therapy, and topical bactericide. It was discovered to be carcinogenic in 1943 and largely ineffective at treating multiple myeloma, according to a study published in 1966. It was removed from the market in the US, UK and Canada in 1963 and was classified as a 2B carcinogen by the IARC in 1974. However, its use in Japan as a co-solvent in water for dissolving water-insoluble analgesics used for post-operation pain, at doses estimated to be at levels that are carcinogenic in mice, continued until 1975. Miller has suggested that this may have been the "largest number (millions) of humans exposed to the largest doses of a pure carcinogen that is on record" and called for studies to determine the effects on Japanese cancer rates to be performed. Ethyl carbamate continues to be used as an anaesthetic in animal experiments, with more than 100 animal studies using ethyl carbamate published each year. One advantage of using ethyl carbamate is that it has a very long duration of action, with some adult rats remaining anaesthetised 24 hours after administration of the drug. It also does not depress neuronal activity in the cortex to the same extent as isoflurane.
The situation has also reignited a debate over gain-of-function research, although the intense political rhetoric surrounding the issue has threatened to sideline serious inquiry over policy in this domain.
Much of the universe's water is produced as a byproduct of star formation. The formation of stars is accompanied by a strong outward wind of gas and dust. When this outflow of material eventually impacts the surrounding gas, the shock waves that are created compress and heat the gas. The water observed is quickly produced in this warm dense gas. On 22 July 2011, a report described the discovery of a gigantic cloud of water vapor containing "140 trillion times more water than all of Earth's oceans combined" around a quasar located 12 billion light years from Earth. According to the researchers, the "discovery shows that water has been prevalent in the universe for nearly its entire existence". Water has been detected in interstellar clouds within the Milky Way. Water probably exists in abundance in other galaxies, too, because its components, hydrogen, and oxygen, are among the most abundant elements in the universe. Based on models of the formation and evolution of the Solar System and that of other star systems, most other planetary systems are likely to have similar ingredients.
Sources: en.wikipedia.org
=== Skin === The stratum corneum is the outermost layer of the epidermis. It is composed of terminally differentiated and enucleated corneocytes that reside within a lipid matrix, like "bricks and mortar." Together with cholesterol and free fatty acids, ceramides form the lipid mortar, a water-impermeable barrier that prevents evaporative water loss. As a rule of thumb, the epidermal lipid matrix is composed of an equimolar mixture of ceramides (~50% by weight), cholesterol (~ 25% by weight), and free fatty acids (~15% by weight), with smaller quantities of other lipids also being present. The lipid barrier also protects against the entry of microorganisms. Epidermal ceramides have a diversity of structures and can be broadly classified as AS and NS ceramides; ADS and NDS dihydroceramides; AH, EOH, and NH 6-hydroxyceramides; AP and NP phytoceramides; and EOH and EOS acylceramides, see figure.
[T]he Liberals were traditionally the party of freedom of speech, conscience and trade. They were against jingoism, heavy armaments and compulsion. [...] Liberals were neither wholehearted nor unanimous about conscription, censorship, the Defence of the Realm Act, severity toward aliens and pacifists, direction of labour and industry. The Conservatives [...] had no such misgivings. Blake further notes that it was the Liberals, not the Conservatives who needed the moral outrage of Belgium to justify going to war, while the Conservatives called for intervention from the start of the crisis on the grounds of realpolitik and the balance of power. However, Lloyd George and Churchill were zealous supporters of the war, and gradually forced the old peace-orientated Liberals out. Asquith was blamed for the poor British performance in the first year. Since the Liberals ran the war without consulting the Conservatives, there were heavy partisan attacks. However, even Liberal commentators were dismayed by the lack of energy at the top. At the time, public opinion was intensely hostile, both in the media and in the street, against any young man in civilian garb and labeled as a slacker. The leading Liberal newspaper, the Manchester Guardian complained:
== Taxonomy and evolution == The family name Formicidae is derived from the Latin formīca ("ant") from which the words in other Romance languages, such as the Portuguese formiga, Italian formica, Spanish hormiga, Romanian furnică, and French fourmi are derived. The family belongs to the order Hymenoptera, which also includes sawflies, bees, and wasps. Ants evolved from a lineage within the stinging wasps, and a 2013 study suggests that they are a sister group of the Apoidea. However, since Apoidea is a superfamily, ants must be upgraded to the same rank. A more detailed basic taxonomy was proposed in 2020. Three species of the extinct mid-Cretaceous genera Camelomecia and Camelosphecia were placed outside of the Formicidae, in a separate clade within the general superfamily Formicoidea, which, together with Apoidea, forms the higher-ranking group Formicapoidina. Fernández et al. (2021) suggest that the common ancestors of ants and apoids within the Formicapoidina probably existed as early as in the end of the Jurassic period, before divergence in the Cretaceous.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.
No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.
The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.